Cargando…

Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion

Autoimmune rheumatic diseases may affect vital organs with lung involvement being severe and difficult to treat manifestation. Systemic sclerosis (SSc) commonly affects the lung in the form of interstitial lung disease (ILD). ILD may be also seen in patients with rheumatoid arthritis (RA), Sjögren&#...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liossis, Stamatis-Nick C., Bounia, Constantina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279739/ https://www.ncbi.nlm.nih.gov/pubmed/35847798 http://dx.doi.org/10.3389/fmed.2022.937561

Ejemplares similares

B Cell Depletion Treatment in Resistant Systemic Sclerosis Interstitial Lung Disease
por: Bounia, Constantina A., et al.
Publicado: (2022)

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

The Role of B Cells in Scleroderma Lung Disease Pathogenesis
por: Liossis, Stamatis-Nick C., et al.
Publicado: (2022)

Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
por: Bounia, Constantina A, et al.
Publicado: (2021)

A 40-Year-Old Woman with Asymmetric Arthritis and Skin Lesions
por: Bounia, Konstantina A., et al.
Publicado: (2019)

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence
por: Daoussis, Dimitrios, et al.
Publicado: (2011)

What's New in the Treatment of Systemic Lupus Erythematosus
por: Liossis, Stamatis Nick, et al.
Publicado: (2021)

B cells tell scleroderma fibroblasts to produce collagen
por: Daoussis, Dimitrios, et al.
Publicado: (2013)

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin
por: Daoussis, Dimitrios, et al.
Publicado: (2012)

Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
por: Bosello, Silvia Laura, et al.
Publicado: (2021)

Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease
por: Wang, Yukai, et al.
Publicado: (2022)

B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis
por: Daoussis, Dimitrios, et al.
Publicado: (2016)

Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
por: Dsouza, Kevin G., et al.
Publicado: (2023)

B cell depletion in autoimmune disease
por: Gorman, Claire, et al.
Publicado: (2003)

Interstitial Pneumonia With Autoimmune Features (IPAF)
por: Fernandes, Ligia, et al.
Publicado: (2019)

Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
por: Daoussis, Dimitrios, et al.
Publicado: (2019)

68-year old woman with refractory cutaneous dermatomyositis
por: Antonopoulos, Ioannis, et al.
Publicado: (2018)

Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
por: Hervier, Baptiste, et al.
Publicado: (2020)

From Basic Immunology to Clinical Practice: Bio-Originators versus Bio-Similars
por: Liossis, Stamatis-Nick C., et al.
Publicado: (2019)

Clinical Genetics in Interstitial Lung Disease
por: Newton, Chad A., et al.
Publicado: (2018)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Role of the Microbiome in Interstitial Lung Diseases
por: Chioma, Ozioma S., et al.
Publicado: (2021)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Dkk1: A key molecule in joint remodelling and fibrosis
por: Klavdianou, Kalliopi, et al.
Publicado: (2017)

Variability in Global Prevalence of Interstitial Lung Disease
por: Kaul, Bhavika, et al.
Publicado: (2021)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Editorial: Interstitial Lung Disease Around the World
por: Wijsenbeek, Marlies, et al.
Publicado: (2022)

Novel diagnostic techniques in interstitial lung disease
por: Glenn, Laura M., et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature
por: Salamaliki, Christina, et al.
Publicado: (2020)

Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard
por: Lee, Cathryn T., et al.
Publicado: (2022)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022)

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
por: Case, Amy Hajari
Publicado: (2022)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease
por: Lee, Hyun, et al.
Publicado: (2022)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
por: Laria, Antonella, et al.
Publicado: (2022)

Diagnosing interstitial lung disease by multidisciplinary discussion: A review
por: Glenn, Laura M., et al.
Publicado: (2022)

Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
por: Liang, Junyu, et al.
Publicado: (2021)

Unilateral Autoimmune Pulmonary Alveolar Proteinosis with Polymyositis-related Interstitial Lung Disease
por: Muto, Yutaka, et al.
Publicado: (2022)

Calcified lymph nodes and systemic sclerosis
por: Angelopoulou, Fotini, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s03tet5jqovild0iibo3raj84s